Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenicity
Author(s) -
Laurence Bénit,
G. Courtois,
M Charon,
P. Varlet,
Isabelle DusanterFourt,
Sylvie Gisselbrecht
Publication year - 1994
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.68.8.5270-5274.1994
Subject(s) - biology , virus , haematopoiesis , murine leukemia virus , virology , fusion gene , leukemia , microbiology and biotechnology , myeloproliferative disorders , cytoplasm , fusion protein , gene , stem cell , genetics , recombinant dna , immunology
v-mpl is a truncated form of a receptor-like chain which belongs to the cytokine receptor superfamily. This sequence has been transduced in the myeloproliferative leukemia virus as an env-mpl fusion gene responsible for an acute myeloproliferative disorder in mice. We constructed a series of viral mutants in the mpl sequence. Analysis of their oncogenic potential in vivo indicated that a critical 69-amino-acid-long cytoplasmic domain of v-Mpl is required for myoproliferative leukemia virus pathogenicity. We also developed an in vitro assay and showed that expression of the env-mpl gene confers growth factor independence to murine as well as to human hematopoietic growth factor-dependent cell lines. These findings strongly suggest that v-Mpl delivers a constitutive proliferative signal through a limited region of its cytoplasmic domain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom